PHASE Scientific Americas Blog
REVIEW TRENDING INDUSTRY, BUSINESS & GOVERNMENT INFORMATION
May is Women’s Health Month
Every household has a person with the job description of “chief medical officer.” While not an official title, the job involves researching and deciding the best healthcare action for the family. There is an excellent […]
INDICAID DETECTS COVID-19 OMICRON VARIANTS WITH GREATER SENSITIVITY THAN OTHERS
Test recognizes new COVID omicron variant XBB.1.16 which is seeing a rise throughout the United States
(GARDEN GROVE, CA,) – April 18th, 2023 – PHASE Scientific Americas, a fast-growing biotechnology company, announces […]
NURSING AND THE DX EVOLUTION
March 23, 2023
The pandemic accelerated transformation in nursing and diagnostics. One result? The healthcare sector needs to better train the next generation of nurses on how to use new diagnostic technologies and how to counsel […]
THE DIAGNOSTIC PARTNER: ADDRESSING THE EQUITY IMPLICATIONS OF HEALTH DIAGNOSTICS
February 27, 2023
Achieving health equity, in which everyone has a fair and just opportunity to attain their highest level of health, requires ongoing efforts to address historical and contemporary injustices, overcome barriers to healthcare access, […]
THE DIAGNOSTIC PARTNER: EXPANDING THE USE OF TEST-TO-TREAT IN THE POST-PANDEMIC WORLD
February 20, 2023
The federal COVID-19 Test-to-Treat program launched in March 2022 but the test-to-treat response to infectious disease isn’t new. It does need renewal, however.
Test-to-treat describes an early intervention approach to infectious disease in which […]
OMICRON VARIANT UPDATE
November 21, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen Test.
An independent evaluation by the National […]
Targeting COVID-19 Absenteeism with Test to Treat Approach
By Doug Field, Chief Revenue Officer, PHASE Scientific Americas
While the recent surges of current COVID-19 variants are not driving high levels of hospitalization and death, the persistent, circulating virus continues to affect employees and spike […]
How Often Can I Be Infected with the Coronavirus?
July 15, 2022 (reprint of article by Apoorva Mandavilli, NY Times)
A virus that shows no signs of disappearing, variants that are adept at dodging the body’s defenses, and waves of infections two, […]
This Covid Wave Might Be The Start Of Our ‘New Normal’
June 11, 2022 (reprint of article byElizabeth Yuko, Special to CNBC – Make It)
Packed indoor events and fully booked flights where masks are few and far between suggest that the pandemic is […]
INDICAID’S Omicron Variant Update
INDICAID’s Omicron BA.2 Variant Update
April 04, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen test. A sub-variant […]
Facing the “Stealth Omicron” Sub-variant’s Dominance Head-On
No New Surges Means Good Preventive Care
Despite its pervasiveness and spikes in Asia and Europe, the Covid-19 Omicron BA.2—dubbed the Stealth Omicron by the World Health Organization (WHO)—has appeared to have lost its choke-hold on […]
A Premium At-Home COVID-19 Rapid Antigen Testing Product Hits U.S. Retail Stores
PHASE Scientific’s INDICAID® Covid-19 Rapid Antigen Test Obtains FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non-Prescription Use
March 16, 2022 : The biotech conglomerate, PHASE Scientific USA, announced the FDA’s EUA green-light to launch […]
Looking for more to read…
How about reading our corporate News?